Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-11-15
2010-10-19
Landau, Sharmila Gollamudi (Department: 1611)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S411000
Reexamination Certificate
active
07816356
ABSTRACT:
Disclosed herein are compounds that bind to a neuronal nicotinic acetylcholine receptor. These compounds posses broad therapeutic use including the treatment of senile dementia, Alzheimer's disease, Parkinson's disease, attention deficit disorder, and the treatment of addictive disorders such as the use of tobacco in smoking or the use of other nicotine containing products. In addition, they have utility as cognitive enhancers, drug therapy for mental and neurological disorders related to a decrease in cholinergic function, for the treatment of obesity, Tourette's syndrome, or ulcerative colitis. Additionally, these compounds have utility as non-opioid analgesics for treatment of acute and chronic pain.
REFERENCES:
patent: 5672601 (1997-09-01), Cignarella
patent: 6630491 (2003-10-01), Zoltewicz et al.
Decker et al. “The role of neuronal nicotinic acetyicholine receptors in antinociception: Effects of ABT-594” J. Physiology (Paris) 1998, 92, 221-224.
News Release: “New drug may give smokers promising new option for kicking habit,” Oct. 2, 2003, Massachusetts General Hospital, available at: http://www.mgh.harvard.edu
ews/releases/100203smoking.html.
Quit Smoking News “Varenicline and the 7 Day Smoke Away,” at http://www.smoke-away.info/quit-smoking-news.htm, accessed Oct. 24, 2003.
Roan, Shari, Los Angeles Times, “Quitting for Good,” Oct. 20, 2003.
Drug Report: varencline tartrate, The Investigative Drugs Database, http://www.iddb3.com, accessed Oct. 24, 2003.
Burns & Levinson LLP
Klinkel Kortney L
Korkhin Yakov
Landau Sharmila Gollamudi
Susan Janine M
LandOfFree
Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4241645